




Searching News Database: Wyeth
HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 11 Aug 2020
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Acquist Therapeutics Announces New Appointments to its Board of Directors
HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
HSMN NewsFeed - 19 Dec 2019
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
HSMN NewsFeed - 23 Apr 2018
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
OrphoMed Appoints Gary M. Phillips, M.D. as President and Chief Executive Officer
HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
HSMN NewsFeed - 26 Oct 2016
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
HSMN NewsFeed - 30 May 2016
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
HSMN NewsFeed - 17 Jan 2016
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
HSMN NewsFeed - 7 Dec 2015
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
Syros Pharmaceuticals Appoints David A. Roth, M.D., as Chief Medical Officer
HSMN NewsFeed - 5 Nov 2015
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
HSMN NewsFeed - 16 Jul 2015
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 1 Apr 2015
ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer
ImmunoGen, Inc. Appoints Anna Berkenblit, MD, MMSc Vice President and Chief Medical Officer
HSMN NewsFeed - 23 Sep 2014
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
Soligenix Appoints Rasappa Arumugham, PhD, as Vice President of Biopharmaceutical Development
HSMN NewsFeed - 30 Jul 2014
Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
HSMN NewsFeed - 25 Jul 2013
Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
Promentis Pharmaceuticals, Inc. Appoints Industry Veteran Chad Beyer, Ph.D., MBA, as President and CEO
HSMN NewsFeed - 2 Jul 2013
Arch Therapeutics Introduces Experienced Directors and Executive Leadership
Arch Therapeutics Introduces Experienced Directors and Executive Leadership
HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
HSMN NewsFeed - 12 Jun 2013
Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix(R) Patent
Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix(R) Patent
HSMN NewsFeed - 15 Apr 2013
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
HSMN NewsFeed - 18 Mar 2013
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
HSMN NewsFeed - 13 Feb 2013
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
HSMN NewsFeed - 13 Dec 2012
A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer
A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
HSMN NewsFeed - 1 Jun 2012
WebMD Appoints Pharmaceutical And Consumer Healthcare Industry Innovator Cavan M. Redmond As New CEO
WebMD Appoints Pharmaceutical And Consumer Healthcare Industry Innovator Cavan M. Redmond As New CEO
HSMN NewsFeed - 7 May 2012
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
HSMN NewsFeed - 2 May 2012
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
HSMN NewsFeed - 30 Nov 2011
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
HSMN NewsFeed - 22 Sep 2011
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
Eleven Biotherapeutics Appoints Abbie Celniker, Ph.D., Chief Executive Officer
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
HSMN NewsFeed - 4 Apr 2011
PERCIVIA LLC Appoints Amit D. Munshi, President and Chief Executive Officer
PERCIVIA LLC Appoints Amit D. Munshi, President and Chief Executive Officer
HSMN NewsFeed - 24 Jan 2011
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
HSMN NewsFeed - 6 Dec 2010
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
HSMN NewsFeed - 8 Nov 2010
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
ZIOPHARM Oncology Appoints Brian L. Hamilton, M.D., Ph.D., as Senior Vice President, Clinical Operations
HSMN NewsFeed - 3 Nov 2010
Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
HSMN NewsFeed - 29 Oct 2010
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
HSMN NewsFeed - 5 Oct 2010
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
HSMN NewsFeed - 30 Sep 2010
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
HSMN NewsFeed - 11 Aug 2010
Bionovo Adds Dr. James H. Pickar, Former Executive at Wyeth, to Medical Advisory Board
Bionovo Adds Dr. James H. Pickar, Former Executive at Wyeth, to Medical Advisory Board
HSMN NewsFeed - 20 Jul 2010
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
HSMN NewsFeed - 3 Jun 2010
EPEMED, the European Personalised Medicine Association, Appoints Executive Director
EPEMED, the European Personalised Medicine Association, Appoints Executive Director
HSMN NewsFeed - 26 May 2010
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
HSMN NewsFeed - 15 Mar 2010
Bausch & Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer
Bausch & Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer
HSMN NewsFeed - 11 Feb 2010
Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs
Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs
HSMN NewsFeed - 20 Jan 2010
Constellation Pharmaceuticals Appoints Industry Veteran Garen Bohlin to Senior Management Group
Constellation Pharmaceuticals Appoints Industry Veteran Garen Bohlin to Senior Management Group
HSMN NewsFeed - 15 Jan 2010
St. Jude Medical Announces Sponsorship of SCD-HeFT 10-Year Follow-Up Study
St. Jude Medical Announces Sponsorship of SCD-HeFT 10-Year Follow-Up Study
HSMN NewsFeed - 8 Jan 2010
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
HSMN NewsFeed - 8 Dec 2009
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
HSMN NewsFeed - 2 Dec 2009
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer
HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
HSMN NewsFeed - 25 Sep 2009
Frances D. Fergusson And John P. Mascotte Elected To Pfizer's Board Of Directors
Frances D. Fergusson And John P. Mascotte Elected To Pfizer's Board Of Directors
HSMN NewsFeed - 15 Sep 2009
Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with Bazedoxifene
Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with Bazedoxifene
HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
HSMN NewsFeed - 17 Jul 2009
Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth
Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth
HSMN NewsFeed - 19 May 2009
Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing
Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing
HSMN NewsFeed - 31 Mar 2009
TYRX Announces the Appointment of George D. Landau as Vice President, Business Development
TYRX Announces the Appointment of George D. Landau as Vice President, Business Development
HSMN NewsFeed - 13 Mar 2009
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
HSMN NewsFeed - 11 Mar 2009
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
HSMN NewsFeed - 26 Jan 2009
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
HSMN NewsFeed - 17 Dec 2008
HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor
HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor
HSMN NewsFeed - 12 Dec 2008
Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs
Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs
HSMN NewsFeed - 27 Nov 2008
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
HSMN NewsFeed - 17 Nov 2008
Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
HSMN NewsFeed - 23 Sep 2008
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
HSMN NewsFeed - 18 Sep 2008
Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
HSMN NewsFeed - 10 Sep 2008
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
HSMN NewsFeed - 4 Sep 2008
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
HSMN NewsFeed - 18 Aug 2008
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
HSMN NewsFeed - 14 Jul 2008
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
Noven Names Joel Lippman, M.D. as Vice President - Clinical Development & Chief Medical Officer
HSMN NewsFeed - 18 Jun 2008
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
HSMN NewsFeed - 17 Jun 2008
Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for Levoleucovorin for Injection
Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for Levoleucovorin for Injection
HSMN NewsFeed - 16 Jun 2008
Mylan Announces Final FDA Approval for Generic Version of Antidepressant Effexor(R)
Mylan Announces Final FDA Approval for Generic Version of Antidepressant Effexor(R)
HSMN NewsFeed - 9 Jun 2008
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
HSMN NewsFeed - 5 Jun 2008
New Drug Application Filing for Levoleucovorin Tablets Completed by Spectrum Pharmaceuticals, Inc.
New Drug Application Filing for Levoleucovorin Tablets Completed by Spectrum Pharmaceuticals, Inc.
HSMN NewsFeed - 4 Jun 2008
Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
HSMN NewsFeed - 28 May 2008
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
HSMN NewsFeed - 23 May 2008
Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl
Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl
HSMN NewsFeed - 23 May 2008
Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
HSMN NewsFeed - 1 Apr 2008
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approval
HSMN NewsFeed - 31 Mar 2008
IMPAX Establishes Branded Products Division with Appointments of Senior Management
IMPAX Establishes Branded Products Division with Appointments of Senior Management
HSMN NewsFeed - 18 Mar 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
HSMN NewsFeed - 17 Mar 2008
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for Enbrel(R)
HSMN NewsFeed - 17 Mar 2008
Avalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of Directors
Avalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of Directors
HSMN NewsFeed - 10 Mar 2008
Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
HSMN NewsFeed - 7 Mar 2008
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
HSMN NewsFeed - 3 Mar 2008
Crucell Announces Vaccine Development Agreement with Wyeth Pharmaceuticals
Crucell Announces Vaccine Development Agreement with Wyeth Pharmaceuticals
HSMN NewsFeed - 20 Feb 2008
New Breakthrough Treatment for Advanced Kidney Cancer Shows 49 Per Cent Higher Survival Rates
New Breakthrough Treatment for Advanced Kidney Cancer Shows 49 Per Cent Higher Survival Rates
HSMN NewsFeed - 4 Feb 2008
Promedior Adds to Management Team and Announces Extension of Series A Financing
Promedior Adds to Management Team and Announces Extension of Series A Financing
HSMN NewsFeed - 30 Jan 2008
Prasco to Distribute Wyeth's Own Generic Versions of Protonix(R) Delayed-Release Tablets
Prasco to Distribute Wyeth's Own Generic Versions of Protonix(R) Delayed-Release Tablets
HSMN NewsFeed - 22 Jan 2008
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
HSMN NewsFeed - 24 Dec 2007
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
HSMN NewsFeed - 19 Dec 2007
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
HSMN NewsFeed - 12 Dec 2007
New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
HSMN NewsFeed - 27 Nov 2007
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
Neuromed Appoints Jeffrey Arcara and Gene Wright to Senior Management Team
HSMN NewsFeed - 26 Nov 2007
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
HSMN NewsFeed - 19 Nov 2007
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development
HSMN NewsFeed - 15 Nov 2007
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
HSMN NewsFeed - 23 Oct 2007
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
HSMN NewsFeed - 15 Oct 2007
Ligand Earns Milestone Payment as Wyeth Submits European Market Authorization for Bazedoxifene
Ligand Earns Milestone Payment as Wyeth Submits European Market Authorization for Bazedoxifene
HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
HSMN NewsFeed - 27 Sep 2007
Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
HSMN NewsFeed - 20 Sep 2007
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
HSMN NewsFeed - 19 Sep 2007
Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 12 Sep 2007
Flamel Technologies Announces Medusa(R) License Agreement with Wyeth Pharmaceuticals
Flamel Technologies Announces Medusa(R) License Agreement with Wyeth Pharmaceuticals
HSMN NewsFeed - 29 Aug 2007
Wyeth and Progenics Submit Marketing Application in Australia for Subcutaneous Methylnaltrexone
Wyeth and Progenics Submit Marketing Application in Australia for Subcutaneous Methylnaltrexone
HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
HSMN NewsFeed - 17 Aug 2007
Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
HSMN NewsFeed - 2 Aug 2007
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
HSMN NewsFeed - 30 Jul 2007
Elusys Appoints New Chairman of the Board and a Vice President of Development
Elusys Appoints New Chairman of the Board and a Vice President of Development
HSMN NewsFeed - 30 Jul 2007
Lybrel, First Low Dose Combination Oral Contraceptive with Unique 365-Day Dosing, Now Available in U.S.
Lybrel, First Low Dose Combination Oral Contraceptive with Unique 365-Day Dosing, Now Available in U.S.
HSMN NewsFeed - 27 Jul 2007
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
HSMN NewsFeed - 29 Jun 2007
Wyeth Announces Election of Mary Katherine Wold as Senior Vice President, Finance
Wyeth Announces Election of Mary Katherine Wold as Senior Vice President, Finance
HSMN NewsFeed - 27 Jun 2007
NUCRYST Pharmaceuticals appoints Katherine J. Turner, PhD to Vice President, Research and Development
NUCRYST Pharmaceuticals appoints Katherine J. Turner, PhD to Vice President, Research and Development
HSMN NewsFeed - 27 Jun 2007
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
HSMN NewsFeed - 6 Jun 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
HSMN NewsFeed - 5 Jun 2007
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
HSMN NewsFeed - 3 Jun 2007
Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO
Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO
HSMN NewsFeed - 1 Jun 2007
Semafore Pharmaceuticals Appoints Dr. Ullrich Schwertschlag Chief Medical Officer
Semafore Pharmaceuticals Appoints Dr. Ullrich Schwertschlag Chief Medical Officer
HSMN NewsFeed - 30 May 2007
FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed - 21 May 2007
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
HSMN NewsFeed - 1 May 2007
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
HSMN NewsFeed - 27 Apr 2007
Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company
Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company
HSMN NewsFeed - 24 Apr 2007
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
HSMN NewsFeed - 24 Apr 2007
Exelixis Reinitiates Clinical Development of XL999 in Patients With Non-Small Cell Lung Cancer
Exelixis Reinitiates Clinical Development of XL999 in Patients With Non-Small Cell Lung Cancer
HSMN NewsFeed - 18 Apr 2007
Wyeth Responds to Special Report Published in New England Journal of Medicine
Wyeth Responds to Special Report Published in New England Journal of Medicine
HSMN NewsFeed - 18 Apr 2007
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
Iroko Pharmaceuticals Appoints John Vavricka as President and Chief Executive Officer
HSMN NewsFeed - 17 Apr 2007
SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
HSMN NewsFeed - 12 Apr 2007
Exelixis Appoints Experienced Clinician and Scientist to Vice President of Translational Medicine
Exelixis Appoints Experienced Clinician and Scientist to Vice President of Translational Medicine
HSMN NewsFeed - 11 Apr 2007
Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
HSMN NewsFeed - 10 Apr 2007
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
HSMN NewsFeed - 10 Apr 2007
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
HSMN NewsFeed - 9 Apr 2007
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
PDL BioPharma Announces Election of L. Patrick Gage as Chairman of the Board
HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
HSMN NewsFeed - 27 Mar 2007
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Sapphire Therapeutics, Inc. Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
HSMN NewsFeed - 26 Mar 2007
EpiCept Corporation Appoints Stephane Allard, M.D. as New Chief Medical Officer
EpiCept Corporation Appoints Stephane Allard, M.D. as New Chief Medical Officer
HSMN NewsFeed - 20 Mar 2007
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07
Cordis Corporation to Emphasize Commitment to Interventional Cardiology at ACC.07
HSMN NewsFeed - 5 Mar 2007
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
HSMN NewsFeed - 5 Feb 2007
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
HSMN NewsFeed - 5 Feb 2007
Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
HSMN NewsFeed - 2 Feb 2007
Survey Indicates People with Chronic Moderate to Severe Plaque Psoriasis May Be Under-Treated
Survey Indicates People with Chronic Moderate to Severe Plaque Psoriasis May Be Under-Treated
HSMN NewsFeed - 2 Feb 2007
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
HSMN NewsFeed - 26 Jan 2007
Schering-Plough Corporation Mourns Death of Bruce R. Reid, Leader in Pharmaceutical Business
Schering-Plough Corporation Mourns Death of Bruce R. Reid, Leader in Pharmaceutical Business
HSMN NewsFeed - 11 Jan 2007
Ash Access Technology, Inc. Appoints Dr. Al Guillem as Vice President, Scientific and Quality Affairs
Ash Access Technology, Inc. Appoints Dr. Al Guillem as Vice President, Scientific and Quality Affairs
HSMN NewsFeed - 10 Jan 2007
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
HSMN NewsFeed - 8 Jan 2007
Progenics Pharmaceuticals Expands Senior Management Team and Board of Directors
Progenics Pharmaceuticals Expands Senior Management Team and Board of Directors
HSMN NewsFeed - 3 Jan 2007
Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
HSMN NewsFeed - 28 Nov 2006
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
HSMN NewsFeed - 16 Nov 2006
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
HSMN NewsFeed - 14 Nov 2006
Inovio Biomedical Grants VGX Pharmaceuticals License to Develop Novel Cancer Therapeutic
Inovio Biomedical Grants VGX Pharmaceuticals License to Develop Novel Cancer Therapeutic
HSMN NewsFeed - 7 Nov 2006
Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
HSMN NewsFeed - 2 Nov 2006
Exelixis Suspends Enrollment of New Patients in XL999 Phase II Clinical Trial Program
Exelixis Suspends Enrollment of New Patients in XL999 Phase II Clinical Trial Program
HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
HSMN NewsFeed - 6 Oct 2006
Wyeth Submits NDA and MAA for Torisel for the Treatment of Advanced Renal Cell Carcinoma
Wyeth Submits NDA and MAA for Torisel for the Treatment of Advanced Renal Cell Carcinoma
HSMN NewsFeed - 5 Oct 2006
Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs
Biotica Enters into a Research and License Agreement with Wyeth for Novel Rapamycin Analogs
HSMN NewsFeed - 4 Oct 2006
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
Plexxikon and Roche Enter Partnership to Develop Targeted Cancer Therapeutic Medicine PLX4032
HSMN NewsFeed - 28 Sep 2006
Wyeth Announces the Election of Raymond J. McGuire to Its Board of Directors
Wyeth Announces the Election of Raymond J. McGuire to Its Board of Directors
HSMN NewsFeed - 12 Sep 2006
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
HSMN NewsFeed - 11 Jul 2006
James L. Freddo, M.D., Joins Anadys Pharmaceuticals as Chief Medical Officer
James L. Freddo, M.D., Joins Anadys Pharmaceuticals as Chief Medical Officer
HSMN NewsFeed - 6 Jul 2006
King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement for ALTACE(R)
King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement for ALTACE(R)
HSMN NewsFeed - 26 Jun 2006
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
HSMN NewsFeed - 22 Jun 2006
Cordis Corporation's Third-Generation Coronary Stent Approved for Use in Europe
Cordis Corporation's Third-Generation Coronary Stent Approved for Use in Europe
HSMN NewsFeed - 17 May 2006
Cordis Corporation Submits Pre-Market Approval Supplement for Direct Stenting
Cordis Corporation Submits Pre-Market Approval Supplement for Direct Stenting
HSMN NewsFeed - 11 May 2006
Cordis Corporation Submits Pre-Market Approval Submission for Reblockage in Coronary Stent
Cordis Corporation Submits Pre-Market Approval Submission for Reblockage in Coronary Stent
HSMN NewsFeed - 8 May 2006
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
PDI Announces Appointment of Michael J. Marquard as Chief Executive Officer
Additional items found! 445

Members Archive contains
445 additional stories matching:
Wyeth
(Password required)
Wyeth
(Password required)